NorthRock Partners’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.62M Buy
66,651
+18,323
+38% +$444K 0.04% 162
2025
Q1
$1.22M Sell
48,328
-1,822
-4% -$46.2K 0.04% 177
2024
Q4
$1.33M Sell
50,150
-20,314
-29% -$539K 0.04% 163
2024
Q3
$2.04M Buy
70,464
+5,392
+8% +$156K 0.07% 123
2024
Q2
$1.82M Buy
65,072
+778
+1% +$21.8K 0.07% 121
2024
Q1
$1.78M Buy
64,294
+3,996
+7% +$111K 0.07% 134
2023
Q4
$1.74M Buy
60,298
+27,039
+81% +$778K 0.07% 132
2023
Q3
$1.1M Buy
33,259
+3,281
+11% +$109K 0.12% 92
2023
Q2
$1.1M Buy
29,978
+2,178
+8% +$79.9K 0.12% 81
2023
Q1
$1.13M Sell
27,800
-6,730
-19% -$275K 0.12% 84
2022
Q4
$1.77M Buy
34,530
+108
+0.3% +$5.53K 0.2% 55
2022
Q3
$1.51M Sell
34,422
-3,994
-10% -$175K 0.18% 61
2022
Q2
$2.01M Buy
38,416
+2,687
+8% +$141K 0.21% 50
2022
Q1
$1.85M Buy
35,729
+2,544
+8% +$132K 0.17% 63
2021
Q4
$1.96M Buy
33,185
+6,079
+22% +$359K 0.15% 63
2021
Q3
$1.17M Sell
27,106
-3,959
-13% -$170K 0.1% 83
2021
Q2
$1.22M Sell
31,065
-5,836
-16% -$229K 0.1% 74
2021
Q1
$1.34M Buy
36,901
+13,107
+55% +$475K 0.12% 67
2020
Q4
$876K Sell
23,794
-4,606
-16% -$170K 0.09% 84
2020
Q3
$989K Buy
28,400
+6,869
+32% +$239K 0.11% 79
2020
Q2
$668K Buy
21,531
+4,885
+29% +$152K 0.08% 100
2020
Q1
$515K Sell
16,646
-19,537
-54% -$604K 0.07% 107
2019
Q4
$1.35M Buy
36,183
+6,819
+23% +$253K 0.14% 88
2019
Q3
$1M Buy
+29,364
New +$1M 0.14% 85
2019
Q1
Sell
-8,846
Closed -$365K 103
2018
Q4
$365K Buy
+8,846
New +$365K 0.11% 52